[
    {
        "Type of cases ": "NSP Cured",
        "I Qtr-2020": "310",
        "II Qtr-2020": "387",
        "III Qtr-2020": "288",
        "IV Qtr-2020": "267",
        "Total 2020": "1252",
        "%": "87.6"
    },
    {
        "Type of cases ": "NSP Treatment completed",
        "I Qtr-2020": "1",
        "II Qtr-2020": "0",
        "III Qtr-2020": "2",
        "IV Qtr-2020": "10",
        "Total 2020": "13",
        "%": "0.9"
    },
    {
        "Type of cases ": "NSP Died",
        "I Qtr-2020": "9",
        "II Qtr-2020": "17",
        "III Qtr-2020": "16",
        "IV Qtr-2020": "15",
        "Total 2020": "57",
        "%": "4.0"
    },
    {
        "Type of cases ": "NSP Failure",
        "I Qtr-2020": "5",
        "II Qtr-2020": "4",
        "III Qtr-2020": "1",
        "IV Qtr-2020": "1",
        "Total 2020": "11",
        "%": "0.8"
    },
    {
        "Type of cases ": "NSP Lost to Follow-up",
        "I Qtr-2020": "11",
        "II Qtr-2020": "9",
        "III Qtr-2020": "5",
        "IV Qtr-2020": "5",
        "Total 2020": "30",
        "%": "2.1"
    },
    {
        "Type of cases ": "NSP Not Evaluated",
        "I Qtr-2020": "2",
        "II Qtr-2020": "2",
        "III Qtr-2020": "6",
        "IV Qtr-2020": "1",
        "Total 2020": "11",
        "%": "0.8"
    },
    {
        "Type of cases ": "NSP Treatment Regimen Changed",
        "I Qtr-2020": "17",
        "II Qtr-2020": "16",
        "III Qtr-2020": "9",
        "IV Qtr-2020": "14",
        "Total 2020": "56",
        "%": "3.9"
    },
    {
        "Type of cases ": "NSP Total",
        "I Qtr-2020": "355",
        "II Qtr-2020": "435",
        "III Qtr-2020": "327",
        "IV Qtr-2020": "313",
        "Total 2020": "1430",
        "%": ""
    },
    {
        "Type of cases ": "NSN/NEP Cured",
        "I Qtr-2020": "0",
        "II Qtr-2020": "0",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "NSN/NEP Treatment completed",
        "I Qtr-2020": "467",
        "II Qtr-2020": "551",
        "III Qtr-2020": "460",
        "IV Qtr-2020": "421",
        "Total 2020": "1899",
        "%": "95.3"
    },
    {
        "Type of cases ": "NSN/NEP Died",
        "I Qtr-2020": "12",
        "II Qtr-2020": "13",
        "III Qtr-2020": "12",
        "IV Qtr-2020": "22",
        "Total 2020": "59",
        "%": "3.0"
    },
    {
        "Type of cases ": "NSN/NEP Failure",
        "I Qtr-2020": "0",
        "II Qtr-2020": "0",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "NSN/NEP Lost to Follow-up",
        "I Qtr-2020": "5",
        "II Qtr-2020": "7",
        "III Qtr-2020": "11",
        "IV Qtr-2020": "4",
        "Total 2020": "27",
        "%": "1.4"
    },
    {
        "Type of cases ": "NSN/NEP Not Evaluated",
        "I Qtr-2020": "3",
        "II Qtr-2020": "1",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "0",
        "Total 2020": "4",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSN/NEP Treatment Regimen Changed",
        "I Qtr-2020": "1",
        "II Qtr-2020": "2",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "1",
        "Total 2020": "4",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSN/NEP Total",
        "I Qtr-2020": "488",
        "II Qtr-2020": "574",
        "III Qtr-2020": "483",
        "IV Qtr-2020": "448",
        "Total 2020": "1993",
        "%": ""
    },
    {
        "Type of cases ": "RT +ve Cured",
        "I Qtr-2020": "86",
        "II Qtr-2020": "60",
        "III Qtr-2020": "59",
        "IV Qtr-2020": "64",
        "Total 2020": "269",
        "%": "79.6"
    },
    {
        "Type of cases ": "RT+ve Treatment completed",
        "I Qtr-2020": "0",
        "II Qtr-2020": "3",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "3",
        "Total 2020": "6",
        "%": "1.8"
    },
    {
        "Type of cases ": "RT +Ve Died",
        "I Qtr-2020": "4",
        "II Qtr-2020": "2",
        "III Qtr-2020": "4",
        "IV Qtr-2020": "3",
        "Total 2020": "13",
        "%": "3.8"
    },
    {
        "Type of cases ": "RT +ve Failure",
        "I Qtr-2020": "1",
        "II Qtr-2020": "0",
        "III Qtr-2020": "3",
        "IV Qtr-2020": "2",
        "Total 2020": "6",
        "%": "1.8"
    },
    {
        "Type of cases ": "RT +ve Lost to Follow-up",
        "I Qtr-2020": "4",
        "II Qtr-2020": "3",
        "III Qtr-2020": "1",
        "IV Qtr-2020": "5",
        "Total 2020": "13",
        "%": "3.8"
    },
    {
        "Type of cases ": "RT +ve Not Evaluated",
        "I Qtr-2020": "1",
        "II Qtr-2020": "0",
        "III Qtr-2020": "1",
        "IV Qtr-2020": "1",
        "Total 2020": "3",
        "%": "0.9"
    },
    {
        "Type of cases ": "RT +ve Treatment Regimen Changed",
        "I Qtr-2020": "8",
        "II Qtr-2020": "10",
        "III Qtr-2020": "2",
        "IV Qtr-2020": "8",
        "Total 2020": "28",
        "%": "8.3"
    },
    {
        "Type of cases ": "RT +ve Total",
        "I Qtr-2020": "104",
        "II Qtr-2020": "78",
        "III Qtr-2020": "70",
        "IV Qtr-2020": "86",
        "Total 2020": "338",
        "%": ""
    },
    {
        "Type of cases ": "RT Neg Cured",
        "I Qtr-2020": "0",
        "II Qtr-2020": "0",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Treatment completed",
        "I Qtr-2020": "67",
        "II Qtr-2020": "66",
        "III Qtr-2020": "67",
        "IV Qtr-2020": "98",
        "Total 2020": "298",
        "%": "96.1"
    },
    {
        "Type of cases ": "RT Neg Died",
        "I Qtr-2020": "0",
        "II Qtr-2020": "3",
        "III Qtr-2020": "3",
        "IV Qtr-2020": "1",
        "Total 2020": "7",
        "%": "2.3"
    },
    {
        "Type of cases ": "RT Neg Failure",
        "I Qtr-2020": "1",
        "II Qtr-2020": "0",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "0",
        "Total 2020": "1",
        "%": "0.3"
    },
    {
        "Type of cases ": "RT Neg Lost to Follow-up",
        "I Qtr-2020": "0",
        "II Qtr-2020": "1",
        "III Qtr-2020": "1",
        "IV Qtr-2020": "0",
        "Total 2020": "2",
        "%": "0.6"
    },
    {
        "Type of cases ": "RT Neg Not Evaluated",
        "I Qtr-2020": "0",
        "II Qtr-2020": "0",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "0",
        "Total 2020": "0",
        "%": "0"
    },
    {
        "Type of cases ": "RT Neg Treatment Regimen Changed",
        "I Qtr-2020": "1",
        "II Qtr-2020": "0",
        "III Qtr-2020": "0",
        "IV Qtr-2020": "1",
        "Total 2020": "2",
        "%": "0.6"
    },
    {
        "Type of cases ": "RT Neg Total",
        "I Qtr-2020": "69",
        "II Qtr-2020": "70",
        "III Qtr-2020": "71",
        "IV Qtr-2020": "100",
        "Total 2020": "310",
        "%": ""
    }
]